USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
APAC Molecular Diagnostics Market, Forecast to 2021
APAC Molecular Diagnostics Market, Forecast to 2021
Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth
RELEASE DATE
23-Mar-2017
23-Mar-2017
REGION
Asia Pacific
Asia Pacific
Research Code: P92E-01-00-00-00
SKU: HC02780-AP-MR_19822
$4,950.00
In stock
SKU
HC02780-AP-MR_19822
Description
The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identified Asia as a market for future growth but have significantly invested in R&D efforts to cater to the Asian population. Genomic studies on Asian population in disease areas like oncology for targeted therapies are constantly on a rise, with active efforts from pharmaceutical and IVD companies. The rise of the private healthcare sector in Asia, with the improvement of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region.
The total MDx industry has been segmented into 4 major areas: infectious diseases, oncology, genetic disorders, and pharmacogenomics. The APAC MDx market was worth $1.72 Billion in 2016 and is expected to reach $2.86 Billion by 2021, at a CAGR of 10.7%. Infectious disease represents the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%) and pharmacogenomics (3.7%).
Cancer incidence has gone up significantly in Asia. Under genetic disorders, non-invasive prenatal testing (NIPT) has great potential with excellent opportunities for future growth. On the technology front, conventional PCR technology is being upgraded with multiplexing capabilities and introduction of automated solutions to cater to high volumes. NGS solutions are gradually making inroads into Asia, especially in developed markets like Singapore, Japan, and South Korea.
This study highlights the growing prominence of MDx industry in Asia, regional trends, growth opportunities, competitive dynamics, and a regional chapter for each of the 11 countries covered in this study.
Area of opportunity in MDx market in the APAC:
• The MDx market in the APAC is evolving with increasing access to established NATs in emerging countries as a result of revamped healthcare practices across the region.
• Oncology care has taken a new dimension in APAC, with the simultaneous rise in prevalence and demand for innovative drugs beyond conventional chemotherapy drugs.
• CDx based oncology drugs are on the rise in the region, with studies targeted for Asian population to demonstrate value. For example, Ono Pharmaceutical’s research on identifying a CDx for Opdivo, introduced in 2014 to stratify patient population.
• Novel genomic tools and technologies are foraying into the APAC to harness the future growth opportunities in the dynamic healthcare ecosystem.
Key questions this study will answer:
• What is the impact of MDx on the IVD industry, given the present healthcare scenario in the APAC?
• Who are the key industry participants in this highly fragment market?
• What are multiple factors impending the growth of MDx in the APAC?
• What are the service delivery models adapted by stakeholders across this region?
• What are the market access strategies for MDx companies aspiring to enter the APAC?
• What is the future of the molecular diagnostics market in the APAC?
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Forecast Methodology
Key Findings
Scope and Segmentation
Market Engineering Measurements
Market Overview—Definitions
8 Big Market Themes for APAC MDx
Trends/Factors Impacting the APAC MDx Market
Key Companies to Watch
Key Predictions
MDx—Transition from Present to Future
Market Segmentation
Market Overview—Segmentation by Application
Role of Molecular Biomarkers in Pharma R&D
Market Overview—Life Cycle Analysis
Key Mergers, Acquisitions, & Partnerships
Market Drivers
Market Restraints
Market Engineering Measurements
Total Molecular Diagnostics Market—Revenue Forecast
Percent Revenue Forecast by Country
Revenue Forecast by Country
Snapshot of Market Participants
Market Snapshot
Market Share by Companies
Competitive Positioning—Seegene
Competitive Positioning—Roche
Competitive Positioning—ThermoFisher
Competitive Positioning—Qiagen
Competitive Positioning—Sysmex
Growth Opportunities—Synergy of 3Ps in APAC
Growth Opportunities—Clinical Trials Market in APAC
Growth Opportunities
Trends for the Adoption of MDx Services in APAC
Future Trends—Direct to Consumer Testing
Future Trends—Niche Clusters to Watch Out for
Future Trends—Point-of-Care Testing (POCT) in MDx
Future Trends—Lifestyle Genomics in APAC
Genome Asia-100K
Polymerase Chain Reaction (PCR)
PCR—Technology Snapshot
In-situ Hybridization (ISH)
Next-Generation Sequencing (NGS)
Cost Implications of NGS
Future of NGS Platform
Drivers for Technology Platforms
MDx Test by Application Scenarios
Infectious Disease Segment—Revenue Forecast
Oncology Segment—Revenue Forecast
Genetic Disorders Segment—Revenue Forecast
Pharmacogenomics Segment—Revenue Forecast
Market Engineering Measurements
China Market—Revenue Forecast
China—Market Drivers
China—Market Restraints
Competitive Structure
Market Engineering Measurements
South Korea Market—Revenue Forecast
South Korea—Market Drivers
South Korea—Market Restraints
Competitive Structure
Market Engineering Measurements
India Market—Revenue Forecast
India—Market Drivers
India—Market Restraints
India—Market Restraints
Market Engineering Measurements
Japan Market—Revenue Forecast
Japan—Market Drivers
Japan—Market Restraints
Competitive Structure
Market Engineering Measurements
Australia Market—Revenue Forecast
Australia—Market Drivers
Australia—Market Restraints
Competitive Structure
Market Engineering Measurements
Taiwan Market—Revenue Forecast
Taiwan—Market Drivers
Taiwan—Market Restraints
Competitive Structure
Market Engineering Measurements
Indonesia Market—Revenue Forecast
Indonesia—Market Drivers
Indonesia—Market Restraints
Competitive Structure
Market Engineering Measurements
Malaysia Market—Revenue Forecast
Malaysia—Market Drivers
Malaysia—Market Restraints
Competitive Structure
Key Trends—Challenges and Opportunities
Market Engineering Measurements
Thailand Market—Revenue Forecast
Thailand—Market Drivers
Thailand—Market Restraints
Competitive Structure
Market Engineering Measurements
Singapore Market—Revenue Forecast
Singapore—Market Drivers
Singapore—Market Restraints
Competitive Structure
Market Engineering Measurements
Philippines Market—Revenue Forecast
Philippines—Market Drivers
Philippines—Market Restraints
Competitive Structure
Market Engineering Measurements
Vietnam Market—Revenue Forecast
Vietnam—Market Drivers
Vietnam—Market Restraints
Competitive Structure
The Last Word—Three Big Predictions
Key Conclusions
Legal Disclaimer
Market Engineering Methodology
List of Figures- 1. Total Molecular Diagnostics Market: Key Market Drivers, APAC, 2017–2021
- 2. Total Molecular Diagnostics Market: Key Market Restraints, APAC, 2017–2021
- 3. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016
- 4. Total Molecular Diagnostics Market: Revenue Forecast by Country, APAC, 2014–2021
- 5. Total Molecular Diagnostics Market: POCT Platforms and Assay Availability by Top Manufacturers, APAC, 2016
- 6. Total Molecular Diagnostics Market: PCR Platforms from Major Companies, APAC, 2016
- 7. Total Molecular Diagnostics Market: Companion Diagnostic Tests for Different Cancer Types, APAC, 2016
- 8. Total Molecular Diagnostics Market: Comparison of Sanger Sequencing and NGS, APAC, 2016
- 9. Total Molecular Diagnostics Market: Overview of Technology Platforms in MDx, APAC, 2016
- 10. Molecular Diagnostics Industry: Market Engineering Measurements, China, 2016
- 11. Molecular Diagnostics Market: Drivers, China, 2017–2021
- 12. Molecular Diagnostics Market: Restraints, China, 2017–2021
- 13. Molecular Diagnostics Market: Competitive Structure, China, 2016
- 14. Molecular Diagnostics Market: Market Engineering Measurements, South Korea, 2016
- 15. Molecular Diagnostics Market: Drivers, South Korea, 2017–2021
- 16. Molecular Diagnostics Market: Restraints, South Korea, 2017–2021
- 17. Molecular Diagnostics Market: Competitive Structure, South Korea, 2016
- 18. Molecular Diagnostics Market: Market Engineering Measurements, India, 2016
- 19. Molecular Diagnostics Market: Drivers, India, 2017–2021
- 20. Molecular Diagnostics Market: Restraints, India, 2017–2021
- 21. Molecular Diagnostics Market: Competitive Structure, India, 2016
- 22. Molecular Diagnostics Market: Market Engineering Measurements, Japan, 2016
- 23. Molecular Diagnostics Market: Drivers, Japan, 2017–2021
- 24. Molecular Diagnostics Market: Restraints, Japan, 2017–2021
- 25. Molecular Diagnostics Market: Competitive Structure, Japan, 2016
- 26. Molecular Diagnostics Market: Market Engineering Measurements, Australia, 2016
- 27. Molecular Diagnostics Market: Drivers, Australia, 2017–2021
- 28. Molecular Diagnostics Market: Restraints, Australia, 2017–2021
- 29. Molecular Diagnostics Market: Competitive Structure, Australia, 2016
- 30. Molecular Diagnostics Market: Market Engineering Measurements, Taiwan, 2016
- 31. Molecular Diagnostics Market: Drivers, Taiwan, 2017–2021
- 32. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021
- 33. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021
- 34. Molecular Diagnostics Market: Market Engineering Measurements, Indonesia, 2016
- 35. Molecular Diagnostics Market: Drivers, Indonesia, 2017–2021
- 36. Molecular Diagnostics Market: Restraints, Indonesia, 2017–2021
- 37. Molecular Diagnostics Market: Competitive Structure, Indonesia, 2016
- 38. Molecular Diagnostics Market: Market Engineering Measurements, Malaysia, 2016
- 39. Molecular Diagnostics Market: Drivers, Malaysia, 2017–2021
- 40. Molecular Diagnostics Market: Restraints, Malaysia, 2017–2021
- 41. Molecular Diagnostics Market: Competitive Structure, Malaysia, 2016
- 42. Molecular Diagnostics Market: Market Engineering Measurements, Thailand, 2016
- 43. Molecular Diagnostics Market: Drivers, Thailand, 2017–2021
- 44. Molecular Diagnostics Market: Restraints, Thailand, 2017–2021
- 45. Molecular Diagnostics Market: Competitive Structure, Thailand, 2016
- 46. Molecular Diagnostics Market: Market Engineering Measurements, Singapore, 2016
- 47. Molecular Diagnostics Market: Drivers, Singapore, 2017–2021
- 48. Molecular Diagnostics Market: Restraints, Singapore, 2017–2021
- 49. Molecular Diagnostics Market: Competitive Structure, Singapore, 2016
- 50. Molecular Diagnostics Market: Market Engineering Measurements, Philippines, 2016
- 51. Molecular Diagnostics Market: Drivers, Philippines, 2017–2021
- 52. Molecular Diagnostics Market: Restraints, Philippines, 2017–2021
- 53. Molecular Diagnostics Market: Competitive Structure, Philippines, 2016
- 54. Molecular Diagnostics Market: Market Engineering Measurements, Vietnam, 2016
- 55. Molecular Diagnostics Market: Drivers, Vietnam, 2017–2021
- 56. Molecular Diagnostics Market: Restraints, Vietnam, 2017–2021
- 57. Molecular Diagnostics Market: Competitive Structure, Vietnam, 2016
List of Charts- 1. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016
- 2. Total Molecular Diagnostics Market: Roles of Biomarkers in the Pharmaceutical Value Chain, APAC, 2016
- 3. Total Molecular Diagnostics Market: Future of Molecular Diagnostics Industry, APAC, 2016
- 4. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Application, APAC, 2016
- 5. Total Molecular Diagnostics Market: Roles of Biomarkers in Pharmaceutical Value Chain, APAC, 2016
- 6. Total Molecular Diagnostics Market: Life Cycle Analysis, APAC, 2016
- 7. Total Molecular Diagnostics Market: Key Mergers, Acquisitions and Partnerships, APAC, 2015–2021
- 8. Total Molecular Diagnostics Market: Revenue Forecast, APAC, 2014–2021
- 9. Total Molecular Diagnostics Market: Percent Revenue by Country, APAC, 2016
- 10. Total Molecular Diagnostics Market: Percent Revenue Forecast by Country, APAC, 2021
- 11. Total Molecular Diagnostics Market: Key Market Participants, APAC, 2016
- 12. Total Molecular Diagnostics Market: Percent Revenue by Companies, APAC, 2016
- 13. Total Molecular Diagnostics Market: Snapshot of Emerging Lifestyle Genetic Tests, APAC, 2016
- 14. Total Molecular Diagnostics Market: MDx Tests in Different Applications, APAC, 2016
- 15. Infectious Disease Segment: Revenue Forecast, APAC, 2014–2021
- 16. Oncology Segment: Revenue Forecast, APAC, 2014–2021
- 17. Genetic Disorders Segment: Revenue Forecast, APAC, 2014–2021
- 18. Pharmacogenomics Segment: Revenue Forecast, APAC, 2014–2021
- 19. Molecular Diagnostics Market: Revenue Forecast, China, 2014–2021
- 20. Molecular Diagnostics Market: Revenue Forecast, South Korea, 2014–2021
- 21. Molecular Diagnostics Market: Revenue Forecast, India, 2014–2021
- 22. Molecular Diagnostics Market: Revenue Forecast, Japan, 2014–2021
- 23. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021
- 24. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021
- 25. Molecular Diagnostics Market: Revenue Forecast, Indonesia, 2014–2021
- 26. Molecular Diagnostics Market: Revenue Forecast, Malaysia, 2014–2021
- 27. Molecular Diagnostics Market: Revenue Forecast, Thailand, 2014–2021
- 28. Molecular Diagnostics Market: Revenue Forecast, Singapore, 2014–2021
- 29. Molecular Diagnostics Market: Revenue Forecast, Philippines, 2014–2021
- 30. Molecular Diagnostics Market: Revenue Forecast, Vietnam, 2014–2021
Popular Topics
The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identified Asia as a market for future growth but have significantly invested in R&D efforts to cater to the Asian population. Genomic studies on Asian population in disease areas like oncology for targeted therapies are constantly on a rise, with active efforts from pharmaceutical and IVD companies. The rise of the private healthcare sector in Asia, with the improvement of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region.
The total MDx industry has been segmented into 4 major areas: infectious diseases, oncology, genetic disorders, and pharmacogenomics. The APAC MDx market was worth $1.72 billion in 2016 and is expected to reach $2.86 billion by 2021, at a CAGR of 10.7%. Infectious disease represents the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%) and pharmacogenomics (3.7%).
Cancer incidence has gone up significantly in Asia. Under genetic disorders, non-invasive prenatal testing (NIPT) has great potential with excellent opportunities for future growth. On the technology front, conventional PCR technology is being upgraded with multiplexing capabilities and introduction of automated solutions to cater to high volumes. NGS solutions are gradually making inroads into Asia, especially in developed markets like Singapore, Japan, and South Korea.
This study highlights the growing prominence of MDx industry in Asia, regional trends, growth opportunities, competitive dynamics, and a regional chapter for each of the 11 countries covered in this study.
Area of opportunity in MDx market in t
| No Index | No |
|---|---|
| Podcast | No |
| Table of Contents | || Forecast Methodology~ | Executive Summary~ || Key Findings~ || Scope and Segmentation~ || Market Engineering Measurements~ || Market Overview—Definitions~ || 8 Big Market Themes for APAC MDx~ || Trends/Factors Impacting the APAC MDx Market~ || Key Companies to Watch~ || Key Predictions~ || MDx—Transition from Present to Future~ | Market Overview~ || Market Segmentation~ ||| Infectious Disease~ ||| Pharmacogenomics~ ||| Oncology~ ||| Genetic Disorders~ || Market Overview—Segmentation by Application~ || Role of Molecular Biomarkers in Pharma R&D~ || Market Overview—Life Cycle Analysis~ | Competitive Playbook~ || Key Mergers, Acquisitions, & Partnerships~ | Drivers and Restraints—Total Molecular Diagnostics Market~ || Market Drivers~ ||| Rise in OOP payments and demand for quality healthcare increase in public healthcare spending and public awareness increases test volume in healthcare settings~ ||| High incidence of communicable and non-communicable diseases increases the opportunity for diagnostics tests~ ||| Focus on preventive healthcare, voluntary diagnostic tests, and payer initiatives to reduce healthcare costs by early stage diagnostics~ || Market Restraints~ ||| Burgeoning healthcare costs; federal initiatives to strengthen primary care to reduce utilization of secondary resources (eg. hospital admission, diagnostic tests)~ ||| Lack of harmonized reimbursement protocols, regulatory standards, and stringent market access protocols~ ||| High cost involved in sophisticated MDx tests; operational and infrastructure costs~ | Forecast and Trends—Total Molecular Diagnostics Market~ || Market Engineering Measurements~ || Total Molecular Diagnostics Market—Revenue Forecast~ || Percent Revenue Forecast by Country~ || Revenue Forecast by Country~ || Snapshot of Market Participants~ || Market Snapshot~ | Competitive Environment~ || Market Share by Companies~ ||| Roche~ ||| Illumina~ ||| Thermofisher~ ||| Agilent~ ||| BGI~ ||| Abbott~ ||| Qiagen~ ||| Others~ || Competitive Positioning—Seegene~ || Competitive Positioning—Roche~ || Competitive Positioning—ThermoFisher~ || Competitive Positioning—Qiagen~ || Competitive Positioning—Sysmex~ | Growth Opportunities~ || Growth Opportunities—Synergy of 3Ps in APAC~ || Growth Opportunities—Clinical Trials Market in APAC~ || Growth Opportunities~ || Trends for the Adoption of MDx Services in APAC~ || Future Trends—Direct to Consumer Testing~ || Future Trends—Niche Clusters to Watch Out for~ || Future Trends—Point-of-Care Testing (POCT) in MDx~ || Future Trends—Lifestyle Genomics in APAC~ || Genome Asia-100K~ | Technology Segments—An Overview~ || Polymerase Chain Reaction (PCR)~ || PCR—Technology Snapshot~ || In-situ Hybridization (ISH)~ || Next-Generation Sequencing (NGS)~ || Cost Implications of NGS~ || Future of NGS Platform~ || Drivers for Technology Platforms~ || MDx Test by Application Scenarios~ | Clinical Application Segment Analysis—Infectious Disease Segment~ || Infectious Disease Segment—Revenue Forecast~ | Oncology Segment~ || Oncology Segment—Revenue Forecast~ | Genetic Disorders Segment~ || Genetic Disorders Segment—Revenue Forecast~ | Pharmacogenomics Segment~ || Pharmacogenomics Segment—Revenue Forecast~ | Regional Forecast Trends and Opportunities— China Molecular Diagnostics Market~ || Market Engineering Measurements~ || China Market—Revenue Forecast~ || China—Market Drivers~ || China—Market Restraints~ || Competitive Structure~ | South Korea Molecular Diagnostics Market~ || Market Engineering Measurements~ || South Korea Market—Revenue Forecast~ || South Korea—Market Drivers~ || South Korea—Market Restraints~ || Competitive Structure~ | India Molecular Diagnostics Market~ || Market Engineering Measurements~ || India Market—Revenue Forecast~ || India—Market Drivers~ || India—Market Restraints~ || India—Market Restraints~ | Japan Molecular Diagnostics Market~ || Market Engineering Measurements~ || Japan Market—Revenue Forecast~ || Japan—Market Drivers~ || Japan—Market Restraints~ || Competitive Structure~ | Australia Molecular Diagnostics Market~ || Market Engineering Measurements~ || Australia Market—Revenue Forecast~ || Australia—Market Drivers~ || Australia—Market Restraints~ || Competitive Structure~ | Taiwan Molecular Diagnostics Market~ || Market Engineering Measurements~ || Taiwan Market—Revenue Forecast~ || Taiwan—Market Drivers~ || Taiwan—Market Restraints~ || Competitive Structure~ | Indonesia Molecular Diagnostics Market~ || Market Engineering Measurements~ || Indonesia Market—Revenue Forecast~ || Indonesia—Market Drivers~ || Indonesia—Market Restraints~ || Competitive Structure~ | Malaysia Molecular Diagnostics Market~ || Market Engineering Measurements~ || Malaysia Market—Revenue Forecast~ || Malaysia—Market Drivers~ || Malaysia—Market Restraints~ || Competitive Structure~ || Key Trends—Challenges and Opportunities~ | Thailand Molecular Diagnostics Market~ || Market Engineering Measurements~ || Thailand Market—Revenue Forecast~ || Thailand—Market Drivers~ || Thailand—Market Restraints~ || Competitive Structure~ | Singapore Molecular Diagnostics Market~ || Market Engineering Measurements~ || Singapore Market—Revenue Forecast~ || Singapore—Market Drivers~ || Singapore—Market Restraints~ || Competitive Structure~ | Philippines Molecular Diagnostics Market~ || Market Engineering Measurements~ || Philippines Market—Revenue Forecast~ || Philippines—Market Drivers~ || Philippines—Market Restraints~ || Competitive Structure~ | Vietnam Molecular Diagnostics Market~ || Market Engineering Measurements~ || Vietnam Market—Revenue Forecast~ || Vietnam—Market Drivers~ || Vietnam—Market Restraints~ || Competitive Structure~ | Conclusion~ || The Last Word—Three Big Predictions~ || Key Conclusions~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ |
| List of Charts and Figures | 1. Total Molecular Diagnostics Market: Key Market Drivers, APAC, 2017–2021~ 2. Total Molecular Diagnostics Market: Key Market Restraints, APAC, 2017–2021~ 3. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016~ 4. Total Molecular Diagnostics Market: Revenue Forecast by Country, APAC, 2014–2021~ 5. Total Molecular Diagnostics Market: POCT Platforms and Assay Availability by Top Manufacturers, APAC, 2016~ 6. Total Molecular Diagnostics Market: PCR Platforms from Major Companies, APAC, 2016~ 7. Total Molecular Diagnostics Market: Companion Diagnostic Tests for Different Cancer Types, APAC, 2016~ 8. Total Molecular Diagnostics Market: Comparison of Sanger Sequencing and NGS, APAC, 2016~ 9. Total Molecular Diagnostics Market: Overview of Technology Platforms in MDx, APAC, 2016~ 10. Molecular Diagnostics Industry: Market Engineering Measurements, China, 2016~ 11. Molecular Diagnostics Market: Drivers, China, 2017–2021~ 12. Molecular Diagnostics Market: Restraints, China, 2017–2021~ 13. Molecular Diagnostics Market: Competitive Structure, China, 2016~ 14. Molecular Diagnostics Market: Market Engineering Measurements, South Korea, 2016~ 15. Molecular Diagnostics Market: Drivers, South Korea, 2017–2021~ 16. Molecular Diagnostics Market: Restraints, South Korea, 2017–2021~ 17. Molecular Diagnostics Market: Competitive Structure, South Korea, 2016~ 18. Molecular Diagnostics Market: Market Engineering Measurements, India, 2016~ 19. Molecular Diagnostics Market: Drivers, India, 2017–2021~ 20. Molecular Diagnostics Market: Restraints, India, 2017–2021~ 21. Molecular Diagnostics Market: Competitive Structure, India, 2016~ 22. Molecular Diagnostics Market: Market Engineering Measurements, Japan, 2016~ 23. Molecular Diagnostics Market: Drivers, Japan, 2017–2021~ 24. Molecular Diagnostics Market: Restraints, Japan, 2017–2021~ 25. Molecular Diagnostics Market: Competitive Structure, Japan, 2016~ 26. Molecular Diagnostics Market: Market Engineering Measurements, Australia, 2016~ 27. Molecular Diagnostics Market: Drivers, Australia, 2017–2021~ 28. Molecular Diagnostics Market: Restraints, Australia, 2017–2021~ 29. Molecular Diagnostics Market: Competitive Structure, Australia, 2016~ 30. Molecular Diagnostics Market: Market Engineering Measurements, Taiwan, 2016~ 31. Molecular Diagnostics Market: Drivers, Taiwan, 2017–2021~ 32. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021~ 33. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021~ 34. Molecular Diagnostics Market: Market Engineering Measurements, Indonesia, 2016~ 35. Molecular Diagnostics Market: Drivers, Indonesia, 2017–2021~ 36. Molecular Diagnostics Market: Restraints, Indonesia, 2017–2021~ 37. Molecular Diagnostics Market: Competitive Structure, Indonesia, 2016~ 38. Molecular Diagnostics Market: Market Engineering Measurements, Malaysia, 2016~ 39. Molecular Diagnostics Market: Drivers, Malaysia, 2017–2021~ 40. Molecular Diagnostics Market: Restraints, Malaysia, 2017–2021~ 41. Molecular Diagnostics Market: Competitive Structure, Malaysia, 2016~ 42. Molecular Diagnostics Market: Market Engineering Measurements, Thailand, 2016~ 43. Molecular Diagnostics Market: Drivers, Thailand, 2017–2021~ 44. Molecular Diagnostics Market: Restraints, Thailand, 2017–2021~ 45. Molecular Diagnostics Market: Competitive Structure, Thailand, 2016~ 46. Molecular Diagnostics Market: Market Engineering Measurements, Singapore, 2016~ 47. Molecular Diagnostics Market: Drivers, Singapore, 2017–2021~ 48. Molecular Diagnostics Market: Restraints, Singapore, 2017–2021~ 49. Molecular Diagnostics Market: Competitive Structure, Singapore, 2016~ 50. Molecular Diagnostics Market: Market Engineering Measurements, Philippines, 2016~ 51. Molecular Diagnostics Market: Drivers, Philippines, 2017–2021~ 52. Molecular Diagnostics Market: Restraints, Philippines, 2017–2021~ 53. Molecular Diagnostics Market: Competitive Structure, Philippines, 2016~ 54. Molecular Diagnostics Market: Market Engineering Measurements, Vietnam, 2016~ 55. Molecular Diagnostics Market: Drivers, Vietnam, 2017–2021~ 56. Molecular Diagnostics Market: Restraints, Vietnam, 2017–2021~ 57. Molecular Diagnostics Market: Competitive Structure, Vietnam, 2016~| 1. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016~ 2. Total Molecular Diagnostics Market: Roles of Biomarkers in the Pharmaceutical Value Chain, APAC, 2016~ 3. Total Molecular Diagnostics Market: Future of Molecular Diagnostics Industry, APAC, 2016~ 4. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Application, APAC, 2016~ 5. Total Molecular Diagnostics Market: Roles of Biomarkers in Pharmaceutical Value Chain, APAC, 2016~ 6. Total Molecular Diagnostics Market: Life Cycle Analysis, APAC, 2016~ 7. Total Molecular Diagnostics Market: Key Mergers, Acquisitions and Partnerships, APAC, 2015–2021~ 8. Total Molecular Diagnostics Market: Revenue Forecast, APAC, 2014–2021~ 9. Total Molecular Diagnostics Market: Percent Revenue by Country, APAC, 2016~ 10. Total Molecular Diagnostics Market: Percent Revenue Forecast by Country, APAC, 2021~ 11. Total Molecular Diagnostics Market: Key Market Participants, APAC, 2016~ 12. Total Molecular Diagnostics Market: Percent Revenue by Companies, APAC, 2016~ 13. Total Molecular Diagnostics Market: Snapshot of Emerging Lifestyle Genetic Tests, APAC, 2016~ 14. Total Molecular Diagnostics Market: MDx Tests in Different Applications, APAC, 2016~ 15. Infectious Disease Segment: Revenue Forecast, APAC, 2014–2021~ 16. Oncology Segment: Revenue Forecast, APAC, 2014–2021~ 17. Genetic Disorders Segment: Revenue Forecast, APAC, 2014–2021~ 18. Pharmacogenomics Segment: Revenue Forecast, APAC, 2014–2021~ 19. Molecular Diagnostics Market: Revenue Forecast, China, 2014–2021~ 20. Molecular Diagnostics Market: Revenue Forecast, South Korea, 2014–2021~ 21. Molecular Diagnostics Market: Revenue Forecast, India, 2014–2021~ 22. Molecular Diagnostics Market: Revenue Forecast, Japan, 2014–2021~ 23. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021~ 24. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021~ 25. Molecular Diagnostics Market: Revenue Forecast, Indonesia, 2014–2021~ 26. Molecular Diagnostics Market: Revenue Forecast, Malaysia, 2014–2021~ 27. Molecular Diagnostics Market: Revenue Forecast, Thailand, 2014–2021~ 28. Molecular Diagnostics Market: Revenue Forecast, Singapore, 2014–2021~ 29. Molecular Diagnostics Market: Revenue Forecast, Philippines, 2014–2021~ 30. Molecular Diagnostics Market: Revenue Forecast, Vietnam, 2014–2021~ |
| Lightbox Content | World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019 |
| Author | Shaillender Muthukumaraswamy |
| Industries | Healthcare |
| WIP Number | P92E-01-00-00-00 |
| Is Prebook | No |